Tetra Radar · FDA Approvals · Decision date
anitocabtagene autoleucel: FDA decision date
Gilead Sciences Inc (GILD) · 23 December 2026
Announced that the Biologics License Application for anito-cel in 4L+ R/R MM has been accepted by FDA, with a PDUFA target action date of December 23, 2026.
Source: 10-Q of 30 October 2026
The decision is pending.
Gilead Sciences Inc on Tetra Radar
A PDUFA date is the date by which the FDA has said it will decide on an application. Dates can move, and a decision is not an approval. Tetra Radar observes public information for research purposes. It does not provide investment advice.